Richardson Financial Services’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-957
Closed -$37.3K 547
2025
Q2
$37.3K Buy
957
+116
+14% +$4.43K 0.03% 279
2025
Q1
$32.6K Buy
841
+472
+128% +$17.3K 0.02% 278
2024
Q4
$12.4K Sell
369
-699
-65% -$25.2K 0.01% 375
2024
Q3
$41.1K Hold
1,068
0.03% 277
2024
Q2
$41.1K Hold
1,068
0.03% 263
2024
Q1
$45.8K Sell
1,068
-9
-0.8% -$371 0.03% 257
2023
Q4
$39.9K Buy
+1,077
New +$38.7K 0.04% 230

Other funds holding GSK

Richardson Financial Services's GSK Position: Q3 2025 in Review

Richardson Financial Services sold out of GSK (GSK) in Q3 2025, closing a stake of 957 shares — an estimated $37.3K sold.

Richardson Financial Services first reported a position in GSK in Q4 2023 and held it in 7 quarters. The position peaked at $45.8K in Q1 2024. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

  • Richardson Financial Services reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
  • Richardson Financial Services sold 957 GSK shares in Q3 2025, an estimated $37.3K.
  • Richardson Financial Services first reported a position in GSK in Q4 2023 and held it in 7 quarters.
  • Richardson Financial Services's GSK position peaked at $45.8K in Q1 2024.
  • 895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Richardson Financial Services's 13F filing for Q3 2025, filed 28 Oct 2025.